Investigating the Detection of Bovine and Soy Proteins in Human Milk
NCT ID: NCT04851340
Last Updated: 2025-01-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
38 participants
INTERVENTIONAL
2020-11-09
2021-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Detection of Metabolite Biomarkers for the Early Diagnosis and Prognosis of Cow's Milk Allergy in Children
NCT04249973
Diagnosis of Cow's Milk Protein Allergy Among Infants and Children in Assuit University Children Hospital
NCT03456479
Infant Formula in Infants and Children With Cow's Milk Allergy
NCT06456541
Prevention of Cow's Milk Allergy in Children
NCT00792090
Effects of Raw Versus Other Milk Sources on Lactose Digestion
NCT01129791
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Breastfeeding affects mortality in children under the age of 5 years old reducing episodes of diarrhea and respiratory infections, and decreasing hospital admissions by up to 70%. The Lancet series on breastfeeding quantified the global economic health impact of breastfeeding on healthcare due to infant illness and mortality. Of the estimated 130 million live births per year globally, 820,000 infant deaths, 87% of which are under 6 months old, could be mitigated with improved breastfeeding practices. The Lancet report projects that a 10% increase in exclusive breastfeeding up to 6 months would translate to an estimated $312 million in healthcare savings in the US alone. Long-term (up to 2 years), additional breastfeeding benefits would impact treatment costs for infants and toddlers as much as $2.45 billion in the US.
Many breastfeeding women are led to believe that they should not eat certain foods (e.g., dairy) because this might lead to food intolerance in their infants. Without a method to directly test human milk, mothers will methodically cut out whole food groups (most of them extremely healthy) without realizing that the true problem is going undetected. This often starts with dairy and quickly spirals until her diet is very limited. A total elimination diet is typical for this community. Many women reduce their intake down to as few as five foods (i.e., chicken, mango, coconut oil, spinach, and potato). This extreme dietary restriction puts mothers and infants at risk for nutritional deficiencies with potential life-long effects.
Currently, there is no mechanism available for mothers to know what allergens are present in their milk. Food diaries are inadequate as dietary protein only enters breastmilk a portion of the time and is present in the milk for a variable amount of time depending on several factors including metabolism, nursing schedule and unknown individual characteristics. A simple at-home test strip would empower women to continue breastfeeding by removing the mystery of the allergens present. Mothers and pediatricians could use this information to determine what is causing reactions and then follow up to determine if informed dietary elimination made mom's milk safe. Women could then enjoy their favorite foods and be confident in feeding their infant.
Free to Feed has developed a first-in-class solution using patent-pending technology to detect food allergen proteins in human milk. With this knowledge, mothers would be able to identify the culprit and remove the food from their diets or wait for the allergen to clear from their milk prior to feeding through repeated testing. This technology hopes to empower mothers to breastfeed longer, giving both mom and baby lifelong benefits, while relieving the stress of inducing unknown effects.
Previous research has identified the presence of specific nonhuman proteins found in human milk. While an abundance of information exists on bovine proteins in human milk, very limited research exists examining the presence of soy proteins in human milk. Furthermore, there is no notable existing research validating the use of strips or other tools to detect food allergens in human milk.
The first aim of this research is to validate the use of this patent-pending technology, Freedom Strips, to detect bovine and soy-based food allergen proteins in human milk with the goal that women will be able to test their milk for common antigens (e.g., dairy) and make informed decisions as to whether the milk should be fed to their infants. This will benefit mothers and babies on a global scale as it will enable women to quickly and easily determine if their milk is safe to feed their infants. A second related aim is to add to current literature by identifying bovine- and soy-derived peptides in human milk after maternal consumption of these foods.
One hypothesis explaining the discomfort and increasingly distressed behavior of infants when consuming human milk containing food allergens relates to potential changes in the gastrointestinal microbiome. There is limited information on the relationship between maternal cow's milk and soy consumption and the gastrointestinal microbiome of mothers and their offspring. Therefore, the third aim of this study is to explore the impact of maternal cow's milk and soy consumption on breastmilk and maternal/infant gastrointestinal microbiomes.
Furthermore, elimination diets, dietary challenges and food reintroduction can put a significant amount of stress on mothers of children with infant food allergies. More research is needed examining how maternal stress levels might change throughout this process. A fourth aim of this study is to examine and compare maternal stress levels during dietary elimination and food challenge periods.
The proposed research study will build upon previous literature by increasing our knowledge related to the detection and identification of nonhuman proteins, specifically bovine and soy, in human milk. This study is unique because it will include a dietary intervention with increasing doses of soy or bovine milk examining how the amount of intake of a food allergen may impact protein detection. It also unique because it includes the investigation of maternal stress and maternal/infant GI microbiomes, both of which may provide more insight on the mechanisms and outcomes of infant food allergies. While our research lab has experience in investigating a variety of factors related to human milk and the microbiome, this study is unique from all other studies currently being done at the University of Idaho.
This study will consist of a randomized, cross-over, dietary intervention research design comprising a 5-day run-in period, two 3-day dietary interventions with a 2-day washout period between them, and a final 2-day washout period after the 2nd intervention. 40 mother-offspring dyads will be recruited to participate. Participants will be randomly assigned to order of intervention. Demographic and health data will be collected at baseline (d0) as will information related to typical infant crying patterns and maternal stress (Perceived Stress Scale). Baseline data collection will also include collection of a human milk sample (approximately 10 mL), a optional maternal stool sample, and an optional infant stool sample. Participants will complete two 24-hour dietary recalls during baseline collection (day 0) rather than one to obtain typical dairy and soy intake.
Run-in elimination period: After baseline collection, both groups will undergo a 5-day run-in period during which time half the subjects will eliminate soy and the other half will eliminate cow's milk. Participants will be provided with a list of foods and ingredients to avoid during this time facilitated by a registered dietitian. During these 5 days, participants will complete a daily compliance check and indicate any soy or bovine products/foods that they may or may not have consumed. On d5 of this run-in period, participants will again provide samples of milk and maternal and infant stool and will complete the Perceived Stress Scale.
Dietary intervention period I: After completing the run-in period, the women will consume 200 mL, 300 mL, and 400 mL of bovine milk or soy milk during d1, d2, and d3 (respectively). During each dietary intervention period, participants will provide 3 samples of milk (approximately 10 mL each) each of the 3 days (12 samples total), 1 maternal stool sample, and 1 infant stool sample. Daily logs will be kept to ascertain dairy and soy intake compliance, infant crying and fussiness, and maternal/infant stooling patterns. On the third day of the dietary intervention, mothers will again complete the Perceived Stress Scale.
Washout period I: Both dietary intervention periods will be followed by a 2-day washout period during which time participants will continue to eliminate bovine or soy containing foods and ingredients. Participants will also complete daily surveys indicating infant behavior and maternal/infant GI symptoms during this washout period.
Dietary intervention period II: After this, each subject will consume 200 mL, 300 mL, and 400 mL of bovine milk or soy milk (which ever they did not consumer in the first intervention period) during d1, d2, and d3 (respectively). Data and samples collected during intervention I will be collected during intervention II.
Washout period II: The second dietary intervention period will be followed by a 2-day washout period during which time they will continue to eliminate the food eliminated in intervention period II. Infant behavior and maternal/infant GI symptoms will again be recorded daily by participants.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cow's Milk First
Participants in this group will eliminate all cow's milk products during the first 10 days of the study and receive the cow's milk intervention first and then will cross-over to eliminate soy products in the second 10 days of the study and receive the soy milk intervention during the second diet intervention.
Cow's Milk
Participants will consume 200 mL, 300 mL, and 400 mL of 1% bovine milk during the diet challenge which occurs on three consecutive days of the study. The first day of the diet challenge participants consume 200 mL, the second day 300 mL and the third day 400 mL.
Soy Milk
Participants will consume 200 mL, 300 mL, and 400 mL of soy milk during the diet challenge which occurs on three consecutive days of the study. The first day of the diet challenge participants consume 200 mL, the second day 300 mL and the third day 400 mL.
Soy Milk First
Participants in this group will eliminate all soy products during the first 10 days of the study and receive the soy milk intervention first and then will cross-over to eliminate cow's milk products in the second 10 days of the study and receive the cow's milk intervention during the second diet intervention.
Cow's Milk
Participants will consume 200 mL, 300 mL, and 400 mL of 1% bovine milk during the diet challenge which occurs on three consecutive days of the study. The first day of the diet challenge participants consume 200 mL, the second day 300 mL and the third day 400 mL.
Soy Milk
Participants will consume 200 mL, 300 mL, and 400 mL of soy milk during the diet challenge which occurs on three consecutive days of the study. The first day of the diet challenge participants consume 200 mL, the second day 300 mL and the third day 400 mL.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cow's Milk
Participants will consume 200 mL, 300 mL, and 400 mL of 1% bovine milk during the diet challenge which occurs on three consecutive days of the study. The first day of the diet challenge participants consume 200 mL, the second day 300 mL and the third day 400 mL.
Soy Milk
Participants will consume 200 mL, 300 mL, and 400 mL of soy milk during the diet challenge which occurs on three consecutive days of the study. The first day of the diet challenge participants consume 200 mL, the second day 300 mL and the third day 400 mL.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Ability to drive to Boise, Idaho or Moscow, Idaho or New York, New York
* Must be currently lactating or breastfeeding
* Mothers of infants aged 0-12 months
* Willing to provide samples of human milk
* Willing to consume 1-2 cups of soy milk and cow's milk daily for 3 days each
Exclusion Criteria
* Individuals unwilling or unable to provide samples of human milk
* Individuals unable to speak and read English
18 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Free to Feed Inc.
UNKNOWN
University of Idaho
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Michelle McGuire
Director of Margaret Ritchie School of Family and Consumer Sciences
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Idaho
Moscow, Idaho, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Quigley MA, Carson C. Breastfeeding in the 21st century. Lancet. 2016 May 21;387(10033):2087-2088. doi: 10.1016/S0140-6736(16)30534-7. No abstract available.
Rollins NC, Bhandari N, Hajeebhoy N, Horton S, Lutter CK, Martines JC, Piwoz EG, Richter LM, Victora CG; Lancet Breastfeeding Series Group. Why invest, and what it will take to improve breastfeeding practices? Lancet. 2016 Jan 30;387(10017):491-504. doi: 10.1016/S0140-6736(15)01044-2.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20-126
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.